69.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$70.64
Aprire:
$70.72
Volume 24 ore:
2.13M
Relative Volume:
1.36
Capitalizzazione di mercato:
$8.44B
Reddito:
$12.50B
Utile/perdita netta:
$314.00M
Rapporto P/E:
28.41
EPS:
2.44
Flusso di cassa netto:
$421.00M
1 W Prestazione:
-6.53%
1M Prestazione:
-2.04%
6M Prestazione:
-3.39%
1 anno Prestazione:
+2.56%
Henry Schein Inc Stock (HSIC) Company Profile
Nome
Henry Schein Inc
Settore
Industria
Telefono
(631) 843-5500
Indirizzo
135 DURYEA RD, MELVILLE, NY
Confronta HSIC con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
HSIC
Henry Schein Inc
|
69.32 | 9.24B | 12.50B | 314.00M | 421.00M | 2.44 |
![]()
MCK
Mckesson Corporation
|
715.74 | 90.44B | 359.05B | 3.30B | 5.23B | 25.83 |
![]()
COR
Cencora Inc
|
297.83 | 57.77B | 310.23B | 1.69B | 3.58B | 8.62 |
![]()
CAH
Cardinal Health Inc
|
161.11 | 39.25B | 222.29B | 1.56B | 2.44B | 6.41 |
![]()
AHG
Akso Health Group Adr
|
1.751 | 514.48M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
2025-01-06 | Aggiornamento | BofA Securities | Underperform → Buy |
2024-12-04 | Iniziato | Mizuho | Neutral |
2024-07-22 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2024-02-26 | Iniziato | Leerink Partners | Market Perform |
2023-12-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
2023-11-10 | Aggiornamento | Stifel | Hold → Buy |
2022-08-08 | Aggiornamento | UBS | Sell → Neutral |
2022-07-21 | Downgrade | Goldman | Buy → Neutral |
2022-06-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
2022-05-13 | Ripresa | Credit Suisse | Outperform |
2022-01-31 | Iniziato | Morgan Stanley | Underweight |
2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2021-10-01 | Ripresa | Credit Suisse | Neutral |
2021-02-08 | Ripresa | Piper Sandler | Overweight |
2021-01-04 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
2020-11-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2020-04-07 | Aggiornamento | Goldman | Neutral → Buy |
2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
2020-01-09 | Downgrade | BofA/Merrill | Neutral → Underperform |
2020-01-02 | Aggiornamento | Evercore ISI | Underperform → In-line |
2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
2019-05-30 | Iniziato | Wolfe Research | Underperform |
2019-05-15 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
2019-04-18 | Iniziato | Guggenheim | Buy |
2019-01-17 | Iniziato | UBS | Sell |
2019-01-03 | Downgrade | Evercore ISI | In-line → Underperform |
2019-01-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
2018-11-08 | Reiterato | Barrington Research | Outperform |
2018-10-25 | Downgrade | Edward Jones | Hold → Sell |
2018-10-19 | Ripresa | Goldman | Neutral |
2018-10-04 | Reiterato | Robert W. Baird | Outperform |
2018-08-07 | Reiterato | Stifel | Hold |
2018-04-24 | Downgrade | Goldman | Buy → Neutral |
2018-04-04 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
Mostra tutto
Henry Schein Inc Borsa (HSIC) Ultime notizie
Henry Schein's Quarterly Earnings Preview: What You Need to Know - inkl
Stanley M. Bergman to retire as CEO of Henry Schein after more than 40 years - Newsday
Stanley Bergman To Retire as Henry Schein’s CEO at the End of The Year - Dentistry Today
Stanley M. Bergman To Retire as Henry Schein’s CEO - citybiz
Henry Schein falls after longtime CEO to retire - TradingView
Henry Schein announces CEO retirement (HSIC:NASDAQ) - Seeking Alpha
Henry Schein CEO Stanley Bergman to Retire at Yearend - MarketScreener
Henry Schein CEO Stanley Bergman Announces Retirement - TipRanks
Stanley M. Bergman to Retire as Henry Schein’s Chief Executive Officer at the End of 2025 - The Globe and Mail
Henry Schein CEO Retires After 35 Years: How He Transformed $225M Company Into $13B Healthcare Giant - Stock Titan
Why Henry Schein Inc. stock attracts strong analyst attentionBig Profit Small Risk Alerts - beatles.ru
Henry Schein Trading Volume Surges 119.05% to Rank 412th Amid Stock Price Decline - AInvest
Henry Schein Stock Downgraded: Potential Loss of Major CustomerNews and Statistics - IndexBox
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why Henry Schein (HSIC) Shares Are Falling Today - Yahoo Finance
This Procter & Gamble Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Baird Downgrades Henry Schein to Neutral From Outperform, Adjusts Price Target to $72 From $82 - MarketScreener
Baird downgrades Henry Schein stock rating on potential customer loss - Investing.com India
Baird downgrades Henry Schein stock rating on potential customer loss By Investing.com - Investing.com UK
Medical distributor Henry Schein opens in Honolulu - Aloha State Daily
On Our Island: : ACLD, H2M, Team Schein and PRPLI - Long Island Business News
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Henry Schein (HSIC) Announces Completion of $250 Million Investment by KKR - Insider Monkey
Evercore ISI Adjusts Price Target on Henry Schein to $78 From $72 - MarketScreener
A Glimpse Into The Expert Outlook On Henry Schein Through 4 Analysts - Benzinga
Should You Retain Henry Schein Stock in Your Portfolio Right Now? - TradingView
Henry Schein's Strategic Acquisitions and Margin Gains: A Path to Sustainable Growth? - AInvest
Farmingdale State College Announces Henry Schein Cares Sensory Unit - MSN
Henry Schein (HSIC) is a Top-Ranked Value Stock: Should You Buy? - Nasdaq
Is Henry Schein Stock Outperforming the Dow? - MSN
Leerink Partners Keeps a Hold Rating on Henry Schein (HSIC) With a $69 PT - Insider Monkey
Here's Why Henry Schein (HSIC) is a Strong Value Stock - Yahoo Finance
Dental Equipment & Technology Stocks Q1 Highlights: Henry Schein (NASDAQ:HSIC) - Yahoo Finance
Here's Why Henry Schein (HSIC) is a Strong Growth Stock - Yahoo Finance
Henry Schein, Inc. (NASDAQ:HSIC) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Henry Schein (HSIC) Updates Credit Agreements to Enhance Financi - GuruFocus
Henry Schein Selects IFS Cloud to Modernize Dental Field Service Operations - Orthodontic Products
KKR is Now a Partial Owner of Henry Schein - Medical Product Outsourcing
Henry Schein Amends $750M Term Loan Agreement - TipRanks
Wellington Management Group LLP Boosts Holdings in Henry Schein, Inc. (NASDAQ:HSIC) - Defense World
Henry Schein, Inc. (NASDAQ:HSIC) Short Interest Up 19.6% in May - Defense World
Henry Schein at Jefferies Global Healthcare: Strategic Growth Focus - Investing.com
Transcript : Henry Schein, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 12 - MarketScreener
Henry Schein Opts for IFS to Optimize Field Service and Streamline Global Operations - Automation.com
Henry Schein Optimizes Services Using IFS - Dentistry Today
Henry Schein (HSIC) Up 6.5% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Updated: Henry Schein to Participate in Upcoming Investor Conference in June | HSIC Stock News - GuruFocus
Updated: Henry Schein to Participate in Upcoming Investor Conference in June - Business Wire
Henry Schein at Stifel Jaws & Paws: Strategic Growth Insights - Investing.com
Transcript : Henry Schein, Inc. Presents at Stifel Jaws & Paws Conference 2025, May-29-2025 12 - marketscreener.com
Henry Schein's BOLD+1 Strategy: A Catalyst for Margin Expansion and EPS Growth in a Tech-Driven Healthcare Landscape - AInvest
Henry Schein Inc Azioni (HSIC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):